| Product Code: ETC319475 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Australia Codeine Phosphate market is a subset of the broader pharmaceutical industry, primarily focused on medications containing codeine phosphate as an active ingredient. Similar to the general codeine market, the codeine phosphate market in Australia experienced significant regulatory changes in 2018, necessitating a prescription for previously over-the-counter medications. These changes aimed to address concerns related to codeine misuse, addiction, and associated health risks. Consequently, the market dynamics shifted, with pharmaceutical companies adapting their strategies to comply with new regulations while ensuring continued access to codeine phosphate-based medications for patients with legitimate medical needs.
In the Australia Codeine Phosphate market, key drivers include the demand for analgesic medications for pain management purposes. Codeine phosphate, a common ingredient in over-the-counter and prescription pain relief formulations, sees demand driven by factors such as the prevalence of pain-related conditions, aging demographics, and the availability of codeine-containing products. Regulatory changes regarding the accessibility and prescribing practices of codeine phosphate also impact market dynamics. Moreover, public awareness campaigns about opioid risks and addiction contribute to shifts in consumption patterns and market behavior.
Similar to the broader codeine market, the Australia Codeine Phosphate market encounters challenges related to regulatory restrictions and public health concerns regarding opioid misuse and addiction. The reclassification of codeine-containing products from over-the-counter to prescription-only has significantly impacted market dynamics. Healthcare professionals now face increased scrutiny and regulatory requirements when prescribing codeine phosphate medications, leading to reduced accessibility for patients and affecting market demand. Moreover, efforts to raise awareness about the risks associated with codeine phosphate consumption contribute to market challenges.
Similar to the broader codeine market, the Australia Codeine Phosphate market is heavily influenced by government regulations governing the availability and distribution of codeine-containing medications. With codeine phosphate being a common form of codeine used in pharmaceutical products, it falls under the same regulatory framework aimed at restricting access to codeine-based medications. The Australia government`s decision to reclassify codeine-containing products as prescription-only has impacted the marketing, distribution, and consumption patterns of codeine phosphate in the country, with implications for pharmaceutical companies and healthcare providers alike.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Codeine Phosphate Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Codeine Phosphate Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Codeine Phosphate Market - Industry Life Cycle |
3.4 Australia Codeine Phosphate Market - Porter's Five Forces |
3.5 Australia Codeine Phosphate Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Australia Codeine Phosphate Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Codeine Phosphate Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pain-related conditions in Australia |
4.2.2 Growing awareness and acceptance of codeine phosphate for pain management |
4.2.3 Rise in geriatric population leading to higher demand for pain medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on codeine-containing products |
4.3.2 Increasing concerns about abuse and addiction potential of codeine phosphate |
5 Australia Codeine Phosphate Market Trends |
6 Australia Codeine Phosphate Market, By Types |
6.1 Australia Codeine Phosphate Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Codeine Phosphate Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 Australia Codeine Phosphate Market Revenues & Volume, By Extracted from Opium, 2021-2031F |
6.1.4 Australia Codeine Phosphate Market Revenues & Volume, By Synthesized by Morphine, 2021-2031F |
6.2 Australia Codeine Phosphate Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Codeine Phosphate Market Revenues & Volume, By Narcotic Analgesic, 2021-2031F |
6.2.3 Australia Codeine Phosphate Market Revenues & Volume, By Antitussive, 2021-2031F |
6.2.4 Australia Codeine Phosphate Market Revenues & Volume, By Others, 2021-2031F |
7 Australia Codeine Phosphate Market Import-Export Trade Statistics |
7.1 Australia Codeine Phosphate Market Export to Major Countries |
7.2 Australia Codeine Phosphate Market Imports from Major Countries |
8 Australia Codeine Phosphate Market Key Performance Indicators |
8.1 Number of prescriptions for codeine phosphate |
8.2 Patient satisfaction and feedback on codeine phosphate efficacy |
8.3 Percentage of healthcare professionals recommending codeine phosphate for pain management |
9 Australia Codeine Phosphate Market - Opportunity Assessment |
9.1 Australia Codeine Phosphate Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Australia Codeine Phosphate Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Codeine Phosphate Market - Competitive Landscape |
10.1 Australia Codeine Phosphate Market Revenue Share, By Companies, 2024 |
10.2 Australia Codeine Phosphate Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |